3 hasil untuk "Mathilde Saint-Ghislain"
Menampilkan 1–3 · 0,49 detik · RSS
-
Artikel Jurnal
Adverse events of targeted therapies approved for women's cancers
Breast cancer and gynecologic cancers affect >3 million women worldwide each year. With advances in precision medicine, a growing number of targeted therapies have been approved recently, and new therapeutic classes have emerged, including cell cycle inhibitors for hormone receptor positive breast…
-
Artikel Jurnal
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
Although combined PD-1/CTLA-4 inhibition showed limited efficacy in single-arm, phase II trials in metastatic uveal melanoma (mUM), such combination appears frequently used in mUM patients. We here report our experience with nivolumab/ipilimumab in mUM. A retrospective cohort of 47 mUM patients, 24…
-
Artikel Jurnal
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)
Abstract Background The identification of homologous recombination deficient (HRD) tumor is now a crucial step for the therapeutic management of ovarian cancer. The HRD tumors are both sensitive to olaparib maintenance treatment and to platinum-based chemotherapy. Despite the large amount of HRD…